PRE CLINICAL TRIAL
- The Reduction of Aorta Histopathological Images Through Inhibition of Reactive Oxygen Species Formation in Hypercholesterolemia Rattus novergicus Treated with Polysaccharide Peptide on Ganoderma lucidum (2014)
- Anti Inflammation and Anti Oxidant Effect of Active Agent Polysaccharide Peptide (Ganoderma lucidum) in Preventing Atherosclerotic Disease (2015)
- Polysaccharide Peptide: A Promising Anti Inflammation and Anti Oxidant in Atherosclerosis (2015)
- Polysaccharide Peptide: A Novel Anti-Inflammation in Reducing Intima Media Proliferation in Diabetic Rats (2015)
- Reducing of Histopathological Images Through a Decrease in H 2 O 2 Levels in Diabetic Rats with Polysaccharide Peptides (2015)
- The Inhibitory Effects of Polysaccharide Peptide (PsP) of Ganoderma lucidum Against Atherosclerosis in Rats with Dyslipidemia (2017)
TOXICOLOGY TRIAL
- Subchronic Toxicity of Ganoderma lucidum Polysaccharide Peptide (PsP) to Liver Physiology and Histopathology Imaging of Liver on Rattus norvegicus strain Wistar Rats (2014)
- Effect of Subchronic Exposure of PsP Ganoderma lucidum on Renal Function and Histopathology Feature in Rattus novergicus Wistar Strain (2015)
- Evaluation Subchronic Toxic Effect of Polysaccharide Peptide on Lipid and Hematologic Profile in Rattus norvegicus strain Wistar (2016)
CLINICAL TRIAL